Introduction
Alzheimer's disease (AD) is a neurodegenerative disease characterized, in part, by the pathogenic accumulation of neuritic beta-amyloid (A␤) plaques accompanied by profound memory loss and neurodegeneration [1] . Although the cause of AD is unknown, studies comparing brain and/or peripheral tissues (e.g. blood) from individuals with AD to cognitively healthy individuals suggest that differences in mitochondrial function [2, 3] , calcium homeostasis [4, 5] , and immune function [6, 7] may be critically involved in the development of AD. As the number of individuals with AD dementia in the United States is expected to reach 14 million by 2050 [8] , the identification of molecules and pathways whose dysfunction leads to AD dementia is critical for understanding the pathogenesis of the disease, as well as for the development of effective therapeutics.
As aging is the most significant risk factor for AD, there is also a critical need to understand mechanisms that occur during normal cognitive aging, as well as how they may contribute to the cognitive decline observed in AD. Our lab has previously shown that a subset of both middle-aged 5XFAD and non-transgenic (Ntg) mice exhibit aging-related hippocampal-dependent memory deficits relative to young 'healthy' mice [9] [10] [11] . In both AD and normal aging, these memory deficits correspond to deficits in intrinsic plasticity of hippocampal neurons (e.g. impaired AHP plasticity after contextual fear conditioning [9, 11] ). The extent to which these previously reported behavioral and neuronal changes observed in 5XFAD and Ntg mice correspond to dysfunction of the same molecular pathways is currently unknown. To identify altered proteins and pathways associated with the development of normal aging and AD memory deficits, this study exploited individual differences in the memory abilities of 8-month-old B6SJL mice harboring human mutations in the genes for amyloid precursor protein (APP) and presenilin1 (PSEN1), which are known to cause early-onset familial AD (5XFAD model), and their Ntg littermates [12] [13] [14] [15] [16] . Mice were diagnosed as having either intact or impaired memory based on their CFM performance relative to a previously tested group of 2-month-old controls [9, 11] , and LC-MS/MS was used to quantify hippocampal membrane proteins across groups. Based on the above evidence, we hypothesize some common molecular mediators contribute to the neuronal plasticity and memory deficits observed in AD and normal aging.
While 5XFAD and Ntg mice do share some similarities (i.e. CFM deficits and impaired AHP plasticity), the neuronal and behavioral deficits observed in 5XFAD mice are exacerbated relative to those observed in normal aging mice. Specifically, the incidence of CFM deficits in middle-aged 5XFAD mice is greatly increased, with ∼70% of 5XFAD mice meeting impaired criteria compared to only ∼30% of Ntg mice. In addition, 5XFAD impaired mice exhibit both CFM deficits and trace-fear memory deficits, whereas age-matched Ntg impaired mice exhibit select CFM deficits [9, 11] . Furthermore, although both AD and normal agingrelated memory deficits in these mice correspond to deficits in intrinsic plasticity (e.g. impaired AHP plasticity after contextual fear conditioning), a reduction in hippocampal neuronal excitability at baseline is only observed in AD mice (see Supl Fig. 2 in . Therefore, we also hypothesize a number of proteins will be differentially expressed relative to memory status only in 5XFAD mice, and that these proteins and corresponding pathways may underlie the exacerbated disease-specific symptoms observed in 5XFAD mice.
As memory deficits in both normal aging and AD correspond to deficits in hippocampal neuronal intrinsic plasticity [9, 11] , we hypothesize that changes in the expression of ion channels and/or receptors that play a key role in regulating neuronal excitability and plasticity [17, 18] may underlie the onset of memory deficits. However, ion channels and receptors are under-represented in many proteomic studies due to the heterogeneous and low-abundant nature of these proteins [19] , especially in comparison to highlyabundant mitochondrial and cytosolic proteins. To reduce this under-sampling bias, we performed a targeted in-depth comparison of the hippocampal membrane proteome from 5XFAD and Ntg mice with either intact or impaired contextual fear memory (CFM). This approach allows for efficient detection of critical proteins that are hypothesized to directly mediate processes necessary for learning and memory that may have been overlooked in previous analyses of the entire hippocampal proteome [20, 21] . In addition, many plasma membrane proteins contain extracellular domains and can be easily manipulated by various chemical compounds or small molecules [22] , making them highly valuable drug targets. Overall, we hypothesize that the identification of hippocampal membrane proteins differentially expressed in AD mice that differ only in memory status may facilitate the prioritization of candidates for subsequent functional tests, as we recently reported in 'normal' aging models [10] .
Materials and methods

Animals
The 5XFAD model of AD used in this study has been previously described [16] . Briefly, 5XFAD mice overexpress mutant human APP695 with the Swedish (K670N, M671L), Florida (I716V), and London (V717I) familial AD (FAD) mutations along with mutant human PS1 harboring two FAD mutations, M146L and L286V. Eightmonth-old male 5XFAD mice and their Ntg littermates were group housed (2-5 per cage) and maintained in colony-housing (12-h light/dark cycle) with ad libitum access to food and water in accordance with approval by the Medical College of Wisconsin Animal Care and Use Committee.
Contextual fear conditioning
Contextual fear conditioning was performed as previously described [9, 11] . Briefly, mice were placed in a training chamber, and after a 150 s baseline period, received four foot shocks (0.7 mA, inter-trial interval 210 ± 10 s). Twenty-four hours later, mice were again placed into the training chamber and behavioral freezing during the 10 min test session was measured as an index of contextual fear memory (CFM). Impaired mice were characterized as those whose CFM performance fell more than 3 standard deviations below that of a group of healthy 2-month-old mice using estab-lished criteria (cutoff = 61%, see Kaczorowski and Disterhoft, 2009, Fig. 2) [9, 11] .
Proteomic analysis
Immediately following CFM testing on Day 2, mice were anesthetized under isoflurane, decapitated, and the entire hippocampus was immediately dissected into ice cold lysis buffer containing protease inhibitors [10] . A membrane enrichment step was performed using freshly isolated hippocampus (n = 4 mice/grp) [10] to reduce abundant mitochondrial and cytosolic proteins that impede detection of lesser-abundant proteins, such as ion channels and receptors [20] . Specifically, samples were homogenized in high salt buffer (2 M NaCl, 10 mM HEPES, 1 mM EDTA, pH 7.4) and centrifuged at 4 • C at 16,000g for 20 min. The remaining pellet was then homogenized in carbonate buffer (0.1 M Na2CO3, 1 mM EDTA, pH 11.3) and incubated at 4 • C for 30 min to separate membrane fractions from free cytosolic proteins and organelles. After incubation, samples were centrifuged at 4 • C at 16,000g for 20 min. Membrane proteins were then extracted from the lipid bilayer by re-dissolving pellet in ice-cold urea buffer (5 M urea, 100 mM NaCl, 10 mM HEPES, 1 mM EDTA, pH 7.4) and centrifuging at 4 • C at 16,000g for 20 min. The remaining pellet was then disrupted and washed with icecold Tris/HCl buffer (pH 7.6), centrifuged 2 x at 4 • C at 16,000g for 20 min, and finally dissolved in 2% SDT-lysis buffer (4% SDS and 100 mM DTT in 0.1 M Tris/HCl buffer, pH 7.6). Samples were heated at 95 • C for 1 min, sonicated for 2 min to shear DNA, and centrifuged at 14,000g for 1 min. The resulting supernatants were then processed using filter-assisted sample preparation (FASP) according to established methods [23] . Tryptic peptides generated from each individual mouse were then analyzed in triplicate using labelfree spectral counting (ms/ms) on a ThermoFinnigan LTQ-Orbitrap Velos Mass Spectrometer coupled to a Waters nano-UPLC system [10] (5 h gradient per run) and ms/ms counts were added together to obtain final ms/ms counts per mouse. Using the Sequest and MASCOT Search algorithms, all sample spectral data was compared against the UniProtKB Mouse Database (generated January 26, 2015; 84,607 sequences, 36,971,481 residues) and a combined file was generated, keeping the best match for a given spectra from one algorithm to avoid redundancies. Search parameters included trypsin digestion, up to 3 missed cleavages, N-terminal Acetylation (+42-Da), oxidation of methione (+16-Da), and carbamidomethyl alkylation of cysteines (+57-Da). A total of 2595 proteins were reliably detected in 3 of the 4 samples of at least one group using a protein probability False Discovery Rate (FDR) of 1% [24] . Of these, 780 had primary annotation as either localized to the plasma membrane or as an ion channel, receptor, or transporter according to Ingenuity Pathway Analysis (IPA; Ingenuity Systems, Redwood City, CA, www.ingenuity.com), a 30% membrane enrichment.
Statistical analysis
Proteomic sample comparisons were performed using Visualize proteomics analysis software with built-in statistical analysis for large proteomic dataset comparison [24] . The G (Goodness-offit) test, which is a log-likelihood ratio test widely accepted for the determination of protein abundance relationships among proteomic datasets, was used to determine statistical significance [25] . The test compares observed protein counts to expected, and calculates a test statistic based on deviation from expected counts. Specifically, the assumption that the expected proportion of scans for a given protein is related to the total scans in each group is used. Thus, each observed scan count is multiplied by this ratio or its inverse (depending on the group) to provide the expected frequency of detection. Scans from group zero (S0) are multiplied by the ratio of total scans in group zero (E0) over the total scans in group one (S1); conversely the inverse is performed for scans from group one (S1) and the total scans from group 1 (E1). Using these assumptions, the G-value calculation is 2 * (S0 * ln(S0/E0) ± S1 * ln(S1/E1)) and if observed frequencies perfectly fit expected frequencies, a G-value of zero is calculated. In contrast, a larger G-value indicates the observed frequency departs from the expected frequency. The G-value distribution can then be approximated by a chi-squared distribution with a single degree of freedom to determine significance [25, 26] . Excel comparison files were exported and protein abundances were determined by quantifying the number of spectra observed for each protein (protein identification FDR set to 1%). Differentially expressed proteins were defined as those proteins with >20% abundance difference based on our prior work validating this cutoff as sufficient to nominate biologically relevant differences in protein expression [10] when identified reliably in at least 3 of the 4 samples of one group (p < 0.05 level using the Bonferroni correction for multiple comparisons). Behavior data is presented at mean ± S.E.M. Data analysis in both behavioral and proteomic experiments were conducted blind to experimental groups.
Bioinformatics analysis
In order to identify networks and pathways that were different between groups, proteins meeting statistical criteria for differential expression from each analysis, along with their log ratio abundance change, were imported into Ingenuity Pathway Analysis (IPA; Ingenuity Systems, Redwood City, CA, www.ingenuity. com) for pathway analysis using the core analysis platform. Build version 366632M and content version 26127183 (release date: 11-30-2015) were used. The core analysis matched proteins in our data sets with those in the Ingenuity Knowledge Base (Genes Only), and only direct relationships were considered for network and upstream regulator analysis. The default settings of 35 molecules/network were retained. Only Ingenuity Expert Information, microRNA-mRNA interactions, and protein-protein interactions with experimentally observed or high confidence predictions were included (moderate confidence interactions were excluded). Data from both mammals (mouse, human, rat) and cell lines were considered. The p-value associated with a function or pathway is calculated using the Fisher Exact Test, which determines the likelihood that the association between experimental results and a given process or pathway is due to random chance. IPA corrects for multiple testing using the Benjamini-Hochberg method [27] to control the rate of false discoveries. To independently validate IPA's identification of HDAC4 as an upstream regulator of observed protein changes, we compared differentially expressed proteins in our analysis with a previous report of transcripts experimentally confirmed to be regulated by HDAC4 [28] . Specifically, the degree of overlap based on gene symbol was determined based on a hypergeometric test. The set of ∼17,000 transcripts measured by the MoGene-1 0-st-v1 Affymetrix microarray was used as the background gene list.
Results
Identification of proteins differentially expressed relative to cognitive status
In order to identify specific proteins and pathways associated with the onset of memory deficits in middle-aged (8-month-old) 5XFAD and Ntg mice, as well as putative candidates that may underlie the exacerbated behavioral and neuronal deficits observed in AD, mice were first diagnosed as either memory-impaired or memoryintact using standard contextual fear conditioning. Specifically, Eight-month-old 5XFAD (AD) mice were trained on standard contextual fear conditioning. AD impaired mice performed below a pre-determined criterion 3 standard deviations below the performance of healthy young mice (61%, dotted line) [9, 11] . AD intact animals performed above criterion. Four mice per group were used for proteomics analysis (3 technical replicates per mouse).
mice were classified as impaired if their CFM fell below our established criteria of three standard deviations away from the mean of 2-month old mice (cutoff = 61%, see Kaczorowski and Disterhoft, 2009 , Fig. 2 ). Four 5XFAD mice with intact CFM (AD intact) and 4 mice with impaired CFM (AD impaired, Fig. 1 Eight-month-old Ntg mice were trained on standard contextual fear conditioning. Memory-impaired mice performed below a pre-determined criterion 3 standard deviations below the performance of healthy young mice (61%, dotted line) [9, 11] . Memory-intact mice performed above criterion. Four mice per group were used for proteomics analysis (3 technical replicates per mouse).
and receptors that are differentially expressed relative to cognitive status support our initial hypothesis that these molecules located in the hippocampal plasma membrane likely modulate resilience or susceptibility to memory decline.
Proteins and pathways that correspond to memory deficits in both 5XFAD and normal aging mice
Of the total proteins identified, 36 proteins were associated with cognitive status in both 5XFAD and Ntg 'normal' aging mice (Table 3 and Supplementary Table 3) , representing a significant degree of overlap between the sets (p = 1.35 × 10 −26 based on a hypergeometric test). For example, glutamate receptors GRIA1 and GRM3, along with synaptic proteins SYN1 and SYNGAP1, were correlated with memory status regardless of genotype. Thus, altered expression of these four proteins, along with the additional 32 overlapping proteins, may contribute to CFM deficits and reductions in hippocampal neuronal excitability and intrinsic plasticity (e.g. impaired AHP plasticity after contextual fear conditioning) that are common to both AD and normal aging mice.
To gain an unbiased perspective of the potential pathways and networks involved in mediating these common changes, this dataset of 36 common differentially expressed proteins was uploaded to IPA for pathway analysis. Based on observed protein abundance changes in our dataset, IPA used bioinformatics to identify glutamate synthesis and degradation, as well as glutamate receptor signaling, as top canonical pathways likely to be responsible for mediating observed differences (Table 4 ). This confirms previous results that highlight synaptic transmission as a core mediator of cognitive function [29] [30] [31] . In addition, IPA identified histone deactylase 4 (HDAC4) as a top predicted upstream regulator mediating observed protein abundance changes (p < 0.001). HDAC4 is known to cause deacetylation of histones and has been shown to regulate expression of genes critical to learning and memory. To independently validate IPA's identification of HDAC4 as an upstream regulator, we compared differentially expressed proteins in our analysis with a previous report of transcripts experimentally determined to be regulated by HDAC4 [28] . Of the 36 proteins we as Table 4 Pathways associated with the onset of memory deficits in both normal ageassociated cognitive decline and AD. Overlapping proteins (36) differentially expressed proteins relative to memory status, 3 correspond to transcripts experimentally determined to be regulated by HDAC4 in neurons by Sando and colleagues in 2012 (out of 210 total transcripts, p < 0.01). This converging evidence further supports a role for HDAC4 as an upstream regulator of proteins involved in the onset of memory deficits common to both AD and normal aging.
Ion channels and receptors associated with memory status at the onset of decline in 5XFAD mice
Despite the significant degree of overlap between proteins associated with the onset of memory deficits in 5XFAD and Ntg mice, a number of unique differentially expressed proteins in each condition were identified. As both the incidence and severity of neuronal and memory deficits are increased in 5XFAD mice, this set of differentially expressed proteins may contribute to exacerbated disease-specific changes that are unique to AD impaired mice [11] . Proteins unique to the onset of AD memory deficits included ion channels and receptors with both excitatory and inhibitory roles in neuronal excitability, confirming previous reports that disruption of the balance between excitation and inhibition within the hippocampus may be critical for AD-related memory and neurological deficits [11, 32] . Specifically, the alpha 1 subunit of the GABA A receptor (GABRA1) and hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1) were all decreased in the hippocampus of AD impaired mice (Supplementary Table 2 ). Identified roles for these channels in the nervous system include plasticity of hippocampal neuronal excitability [33] , modulation of spatial orientation [34] [35] [36] , as well as oscillatory activity in neuronal networks [18, [37] [38] [39] , each of which have been hypothesized to contribute significantly to processes of learning and memory. Notably, levels of GABRA1 [40, 41] , and HCN1 [42] have been reported as decreased in cognitively impaired humans with AD relative to healthy controls, suggesting our work in mouse models can nominate potential translationally relevant molecules.
In addition to changes in neuronal function and excitability, changes in intracellular calcium homeostasis have also been reported prior to the onset of overt clinical symptoms in AD, suggesting this pathway may play a causal role in cognitive decline [4, 43] . In support, ion channels and receptors with known functions in the regulation of calcium homeostasis were identified as misregulated between 5XFAD mice with intact versus impaired CFM. For example, expression of inositol 1,4,5-triphosphate receptor type 1 (IP3R1), which mediates calcium release from internal stores [44] , was increased in 5XFAD mice with intact CFM. IP3R1 has been shown to be co-localized to a specialized subcompartment of the endoplasmic reticulum (ER) called mitochondria-associated ER membranes, which would have also been enriched in our membrane preparation. APP, PSEN1, and presenilin2 (PSEN2) have also been shown to be localized to these mitochondria-associated ER membranes [45] , and along with IP3R1, have been shown to regulate calcium transport between ER and mitochondria [45] . As ER-mitochondrial communication has been proposed as an additional mechanism contributing to AD-related memory deficits [46] , the identification of IP3R1 as misregulated relative to memory status in our animal model provides an additional target that may aid in restoring calcium homeostasis and ER-mitochondrial calcium trafficking in AD.
Pathways associated with memory status at the onset of decline in 5XFAD mice
Similar to the analysis used to identify pathways associated with memory deficits in both normal aging and AD, the list of 103 proteins differentially expressed between AD intact and AD impaired animals was uploaded for pathway analysis. IPA identified repressor element 1 silencing transcription factor (REST) as a top predicted upstream regulator that could explain the unique changes observed in 5XFAD mice (Table 5) . REST, which interacts with chromatin remodeling factors to silence genes important to synaptic function [47] , was recently found to be positively associated with cognitive preservation in human patients who meet post-mortem pathological criteria for AD (i.e. patients with increased REST expression exhibited better cognition, even with AD pathology [48] ). As REST was not identified in analyses using proteome changes associated with cognitive status across genotypes, our results highlight REST as a putative upstream regulator mediating disease-specific changes that contribute to the onset of memory deficits in AD.
One of the top canonical pathways identified by IPA as unique to the onset of memory deficits in 5XFAD mice was G i -mediated intracellular signaling (Table 5 ). The Gi protein is a heterotrimeric G protein subunit that inhibits the production of cAMP from ATP, and activation of this signaling cascade is known to reduce neuronal excitability in hippocampal neurons through activation of a G protein inward-rectifying potassium channel (GIRK) [49, 50] . In addition, this signaling pathway has been shown to inhibit presynaptic voltage-gated Ca 2+ channels, inhibiting Ca 2+ influx and subsequent neurotransmitter release [51, 52] . These results suggest that the exacerbated decrease in intrinsic neuronal excitability and learning-induced plasticity observed in AD impaired mice may be a result of G i signaling and highlight G i -protein coupled receptors (GPCRs) as potential therapeutic targets for early intervention. In particular, the GPCRs MGLUR3 and ADORA1, both identified as Table 2 ).
Proteins and pathways associated with memory status in normal aging mice
In addition to proteins and pathways uniquely differentially expressed relative to memory status in 5XFAD mice, a number of proteins were differentially expressed relative to memory deficits only in Ntg mice. As the cognitive and neuronal deficits observed in the Ntg population are less severe than those identified in 5XFAD mice, these proteins may represent those associated with a maintenance of cognitive function in 'normal' aging. For example, a number of members of the NADH dehydrogenase complex (NDUFA13, NDUFA5, NDUFB7, and NDUFB8) were identified as upregulated in Ntg intact vs Ntg impaired animals (Supplementary Table 1 ). Further bioinformatics by IPA identified oxidative phosphorylation as one of the top canonical pathways that could explain observed protein abundance changes associated with onset of memory deficits in normal aging (Table 6 ).
Confirmatory analysis of proteins and pathways associated with 5XFAD genotype
Previous studies comparing differentially expressed proteins in the hippocampus of FAD mouse models to their corresponding Ntg controls have identified changes in the expression of proteins involved in processes such as autophagy, inflammation, and lipid metabolism, including APOE, PEA14, GFAP, and C1QB, among others [53] [54] [55] . In order to compare and contrast the results of our work with previous studies, we analyzed the hippocampal membrane proteome of AD and Ntg mice regardless of CFM status (n = 8/grp). Analysis of the results identified 139 proteins differentially expressed relative to genotype (Table 7 and Supplementary  Table 4 ) and replicated numerous previously reported findings [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] . For example, the most highly overabundant protein in the hippocampus of 5XFAD mice relative to Ntg controls was clusterin (CLU). The CLU gene has been identified as a risk factor for AD in recent genome-wide association studies, associated particularly with the presence of plaque pathology [59] [60] [61] [62] . Apolipoprotein E (APOE), mutations in which are the most well-characterized risk factor for sporadic AD [66] , was also highly enriched in the hippocampus of 5XFAD mice, demonstrating our ability to replicate known disease-specific changes. In addition to replicating differential expression of CLU and APOE in brain from FAD models compared to Ntg controls, we observed enrichment of adenylate cyclase-associated protein 2 (CAP2) in the hippocampus of 5XFAD relative to Ntg controls. CAP2 has been identified as differentially expressed in both animal models of AD [56] as well as in human AD samples compared to healthy controls [57, 58] . CAP2 plays a role in regulating actin turnover [67] , and is posited to influence structural and molecular remodeling of synapses associated with disease [63] [64] [65] . Overall, both our approach and workflow confirmed previous results and provide new insight into additional proteins and pathways that may have been underrepresented and therefore overlooked in previous studies.
Discussion
The goal of this study was to carefully characterize the hippocampal proteome of middle-aged mice relative to both genotype and memory status while controlling for age in order to identify a narrow set of proteins strongly associated with the development of memory deficits for subsequent functional validation. Here, we present an in depth report of the hippocampus membrane proteome and identify differentially expressed proteins, including plasma membrane ion channels, receptors, and transporters that may play a role in determining the onset and severity of memory deficits in either AD, normal aging, or both.
HDAC4 as a regulator of cognitive deficits across genotypes
As similar behavioral and neuronal deficits are observed in 5XFAD and Ntg mice, we expected a certain degree of overlap in the proteins and pathways associated with the onset of memory deficits in both conditions. In support, bioinformatics analyses highlighted a role for HDAC4 as a key determinant of memory status in both AD and Ntg mice via epigenetic regulation of hippocampal protein expression patterns in response to a training event. It is well-known that epigenetic changes, such as histone modification and methylation, alter chromatin structure in order to facilitate transcription of genes necessary for memory formation [28, 68, 69] . Although it is possible changes in intrinsic neuronal excitability and synaptic transmission influence HDAC4 activity, changes in epigenetic regulation have been linked to specific memory disturbances in animal models of both aging [70] and AD [71] . Although the exact mechanisms are still being elucidated, epigenetic changes appear to be relatively gene-specific and have been linked to intrinsic neuronal excitability, synapse formation, spine density, and dendritic complexity [69, [72] [73] [74] [75] [76] . Genes that have a well-characterized role in learning and memory that are also known to be epigenetically regulated include Bdnf [77] , Creb2 [78, 79] , Reelin [80] , and Pp1 [81] . Here, we provide an additional list of candidates that are differentially expressed relative to memory status and that may also respond to epigenetic regulation downstream of HDAC4 in order to maintain cognitive status in both aging and AD. As the mice used in this study are genetically similar, epigenetics provides a potential explanation for the individual differences in memory status in our models [9, 11] . In humans, a large portion of the heritability of sporadic AD remains unexplained by currently identified genetic variants as measured by GWAS studies [2] . Our data, along with that of others [82, 83] , lends support to the hypothesis that epigenetic changes, whether caused by environmental factors or polymorphisms that regulate methylation status, may explain some of the current 'missing heritability' of AD [84] , as well as underlying mechanisms mediating AD pathophysiology, including dementia symptoms.
Proteins associated with memory deficits in 5XFAD mice may contribute to disease-specific symptoms
It is important to note that although the behavioral and neuronal deficits observed in age-matched 5XFAD and Ntg are similar in some ways (i.e. CFM memory deficits and impaired AHP plasticity), memory deficits occur at a much greater frequency and to a greater extent in 5XFAD mice (see . Thus, the identification of proteins and pathways that are specifically associated with the onset of memory deficits in AD models may help to explain the molecular mediators of exacerbated symptoms, ultimately contributing to the development of therapeutics designed to treat disease-specific symptoms. In addition to changes in intrinsic neuronal excitability and plasticity we have reported previously [9, 11] , evidence suggests that aberrant patterns of neuronal circuit and network activity may also be causally involved in the onset of dementia symptoms in AD [85, 86] . Thus, interventions that block or reverse these changes may prevent development of symptoms [85] . Our work highlights GABRA1 and HCN1, among others, as proteins that may represent viable targets for intervention to prevent or delay the dysfunction in network activity and cognitive deficits observed in AD. HCN1 has recently been linked to the cellular representation of space within the hippocampus via regulation of both place and grid cells [34] [35] [36] . Grid cells in particular have been found to be disrupted in human individuals at risk for Alzheimer's [87] , suggesting early alterations in HCN1 may play a role in the pathophysiology of AD in humans as well as AD mouse models.
Pathways associated with memory deficits in Ntg mice
Our analyses also highlighted oxidative phosphorylation as a unique pathway associated with the onset of cognitive deficits in Ntg mice, which was not surprising based on previous literature linking mitochondrial dyfunction to symptoms of normal aging [88, 89] . Given that mitochondrial proteins are present in relatively high abundance [20] , there has been concern that oversampling of mitochondrial proteins may have biased the results of pathway analysis toward mitochondrial dysfunction in prior studies [20] . However, since our approach incorporates a membrane enrichment step specifically designed to limit this oversampling bias, results here strengthen prior reports that changes in oxidative phosphorylation and overall mitochondrial dysfunction plays an important role in mediating cognitive deficits in 'normal' aging. Although these processes have been associated with memory deficits in AD as well [90] , we speculate that the addition of robust disease-specific factors such as beta-amyloid deposition and gliosis [16] occluded the detection of this pathway in our AD samples, suggesting that other pathways are more strongly associated with the onset of cognitive deficits in AD.
Learning-related changes may be reflected in this reported proteome
Given that all mice in this study were trained on contextual fear conditioning prior to proteomics analyses, the membrane proteome reported here potentially reflects a modified proteome in response to a training event. As naïve untrained mice were not included in this analysis, it is difficult to say for sure whether observed proteome differences are a cause or effect of memory impairment. However, previous reports demonstrate that mice in both memory-impaired and memory-intact groups are capable of learning the task to the same extent on Day 1 of contextual fear conditioning [9, 11] , so differences likely are the result of either consolidation or retrieval processes. Successful consolidation and retrieval is well-known to depend on plasticity of intrinsic neuronal excitability and synaptic strength [17, 91, 92] , which are protein synthesis-dependent processes [93] [94] [95] [96] [97] . Given that protein synthesis and clearance are disrupted in aging and AD models [94, 97] , it is plausible that in AD and Ntg mice with impaired CFM there is either 1) a failure to appropriately remodel the hippocampal proteome, resulting in impaired protein synthesis dependent plasticity or 2) aberrant protein synthesis and remodeling of the proteome that impairs consolidation and/or recall. As ion channels are key mediators of neuronal excitability, the identification of numerous ion channels and receptors differentially expressed relative to memory status in both 'normal' aging and AD provides additional support to this hypothesis.
Considerations for proteomics analyses
Here we used strict protein identification criteria to identify observed proteins, including the identification of a 'razor' peptide that uniquely matches the identified protein. Our FDR for protein identification was set at a strict 1% to minimize false positives. False negative results are also a known caveat inherent to proteomic studies, as current techniques do not yield complete coverage of the entire proteome due to a combination of biological and technical limitations [98, 99] . Therefore, caution should be used when interpreting the absence of a protein within a dataset. For example, a unique razor peptide produced by trypsin digestion may have inherent qualities that prevent ionization and make the peptide incompatible with detection by the mass spectrometer. In contrast, peptides that do ionize well may not be unique, and therefore cannot be reliably attributed to a specific protein [98] . In addition, peptides from a low-abundant protein may elute from the LC column at the same time as those from a much more highly abundant protein, and as such, will not be selected for sequencing by the mass spectrometer. For example, we observed a reliable overexpression of APP in samples from AD compared to Ntg mice (Table 7  and Supplementary Table 4) , whereas peptides matched to PSEN1 were only detected in the hippocampus of one AD impaired and one AD intact animal (none were detected in hippocampi of Ntg mice). While expression of PSEN1 is expected in 5XFAD mice, as the gene encoding this protein is a component of the 5XFAD transgene, this result is consistent with prior observations of higher APP than PSEN1 in the 5XFAD model (Ref. [16] , Fig. 1 ). However, for this reasons discussed above, the failure to reliably detect PSEN1 in 5XFAD mice may well be due to technical limitations, which suggests absolute quantitation using multiple reaction monitoring (MRM) proteomics may be necessary to reliably detect PSEN1 from hippocampal membrane samples. Overall, our analysis of proteins and pathways associated 5XFAD genotype identified a number of proteins previously associated with disease in animal models and humans, including APOE [66] and CLU [59] [60] [61] [62] , demonstrating that our approach and the statistical criteria used to mitigate the risk of both false positive and negatives is capable of capturing a high number of functionally relevant proteins.
Conclusion
Overall, our analyses provides a novel list of proteins that may play a functional role in cellular and molecular process underlying memory decline using methods that permit quantitation of lowabundance membrane proteins that are often underrepresented in proteomic analyses. Here we profile the hippocampal proteome of AD and normal Ntg aging mice following contextual fear training, and then stratify mice into well-defined groups based on their memory performance in order to identify novel proteins likely to be playing a causative role in memory deficits. Taken together, our results highlight novel putative mediators of cognitive decline, and examine the degree to which these molecular biomarkers and corresponding mechanisms overlap and/or diverge in both normal aging and AD. Our results suggest a key role for epigenetic regulation, specifically via HDAC4, in the onset of memory deficits and impaired neuronal excitability that we reported in both AD and normal aging mouse models [9] [10] [11] . Broad HDAC inhibitors have been shown to be effective in treating AD-related memory deficits in mouse models [100] [101] [102] , but knowledge of which HDAC(s) are responsible for the majority of observed effects remains limited [103] . Our identification of HDAC4 as a key upstream regulator of changes in protein abundance relative to memory status in a mouse model of AD may aid in designing more effective and specific inhibitors while reducing off-target effects. In addition, the identification of REST as a disease-specific modulator of memory deficits provides an additional target that may explain exacerbated symptoms in AD compared to normal aging. Ultimately, results here are poised to aid in the development of effective therapeutics for prevention and treatment of both AD and normal cognitive decline and will be made publically available to the scientific community.
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